0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover693.19%IV267.65%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.5609Delta0.1091Gamma2.72Leverage Ratio-0.0303Theta0.0003Rho1.53Eff Leverage0.0021Vega
LAVA Therapeutics Stock Discussion
LAVA Therapeutics N.V., a leader in the biotechnology sector, has recently announced a significant clinical development milestone achieved by Pfizer for the drug PF-08046052. This milestone has prompted the first payment of $7 million to LAVA, marking a notable event in the field of immuno-oncology. $LAVA Therapeutics(LVTX.US)$
https://stockregion.app/p/biotech-leader-announces-7m-milestone
No comment yet